| View |
|
DRP-11898-04
|
Ceftriaxone (as sodium)
|
Zeftrimax
|
1 g
|
Powder for Injection (IM/IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
11 June 2023
|
18 May 2027
|
| View |
|
BR-1344
|
Etanercept
|
Enbrel
|
25 mg/0.5 mL
|
Solution For Injection (S.C.)
|
-
|
Pfizer Manufacturing Belgium NV
|
Belgium
|
Variation
|
11 March 2022
|
11 March 2026
|
| View |
|
BR-1343
|
Etanercept
|
Enbrel
|
50mg/mL
|
Solution For Injection (S.C.)
|
-
|
Pfizer Manufacturing Belgium NV
|
Belgium
|
Initial
|
15 March 2021
|
11 March 2026
|
| View |
|
DRP-7376-09
|
Amlodipine (as Besilate)
|
Pamlodipine
|
10 mg
|
Tablet
|
Calcium Channel Blocker (Dihydropyridine Derivative)
|
Hiral Labs Ltd
|
India
|
CLIDP Conversion
|
05 June 2023
|
26 February 2026
|
| View |
|
DRP-8058-06
|
Losartan Potassium
|
Kodisar
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
22 March 2023
|
29 April 2026
|
| View |
|
DRP-8058-07
|
Losartan Potassium
|
Leesartan
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
05 June 2023
|
29 April 2026
|
| View |
|
DRP-11423-1
|
Linezolid
|
Lizod
|
600 mg
|
Film-Coated Tablet
|
-
|
Lee Pharma Limited
|
India
|
CLIDP Conversion
|
19 May 2023
|
10 March 2027
|
| View |
|
DRP-9896-01
|
Budesonide
|
Rexsonide
|
250 mcg/mL (500 mcg/2mL)
|
Suspension for Nebulization
|
-
|
AXA Parenterals Ltd
|
India
|
CLIDP Conversion
|
09 May 2023
|
24 June 2025
|
| View |
|
DRP-9896-02
|
Budesonide
|
Beuden
|
250 mcg/mL (500 mcg/ 2mL)
|
Suspension for Nebulization
|
-
|
AXA Parenterals Ltd.
|
India
|
CLIDP Conversion
|
17 May 2023
|
24 June 2025
|
| View |
|
DRP-11556
|
Levofloxacin
|
Levohab
|
500mg/100mL
|
Solution For Infusion (IV)
|
Antibacterial
|
Union Korea Pharma Co., Ltd.
|
Korea
|
Initial
|
29 March 2022
|
29 March 2027
|
| View |
DR-XY48852_PI_01.pdf
|
DR-XY48852
|
Finerenone
|
Firialta
|
10 mg
|
Film-Coated Tablet
|
-
|
Bayer AG
|
Germany
|
Monitored Release (MR)
|
23 August 2023
|
23 August 2028
|
| View |
DR-XY48853_PI_01.pdf
|
DR-XY48853
|
Finerenone
|
Firialta
|
20 mg
|
Film-Coated Tablet
|
-
|
Bayer AG
|
Germany
|
Monitored Release (MR)
|
29 August 2023
|
23 August 2028
|
| View |
|
DR-XY42807
|
Cefepime (as hydrochloride)
|
UNIPIM
|
1 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Drug International Limited
|
Bangladesh
|
Renewal
|
29 October 2023
|
14 October 2028
|
| View |
|
DRP-10015-01
|
Cloxacillin (as sodium)
|
Clozac-125
|
125 mg/ 5 mL
|
Powder for Solution
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
09 November 2023
|
25 November 2028
|
| View |
|
DRP-10519-01
|
Butamirate Citrate
|
Coptamed
|
7.5 mg/ 5 mL
|
Syrup (Vanilla Flavor)
|
Antitussive
|
Drugmaker's Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
12 November 2023
|
18 October 2026
|
| View |
|
DRP-10520-01
|
Paracetamol + Hyoscine N-Butylbromide
|
Teracyn
|
500 mg/ 10 mg
|
Film-Coated Tablet
|
Analgesic/ Anticholinergic
|
Drugmaker's Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
12 November 2023
|
08 October 2026
|
| View |
|
DRP-10640-02
|
Fusidic Acid
|
Retasidic
|
20 mg/ g (2% w/w)
|
Ointment
|
Antibacterial
|
Saludcare (I) Pvt. Ltd.
|
India
|
CLIDP Conversion
|
16 November 2023
|
02 November 2026
|
| View |
|
DRP-11451-01
|
Montelukast (as sodium)
|
Gokast-10
|
10 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist
|
Ratnatris Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 November 2023
|
14 March 2027
|
| View |
|
DRP-11453-01
|
Montelukast (as sodium)
|
Gokast-4
|
4 mg
|
Chewable Tablet
|
Leukotriene Receptor Antagonist
|
Ratnatris Pharmaceuticals Private Limited
|
India
|
CLIDP Conversion
|
16 November 2023
|
14 March 2027
|
| View |
|
DRP-11456-02
|
Telmisartan + Amlodipine
|
Temsta
|
40 mg/ 10 mg
|
Tablet
|
Angiotensin II Receptor Blocker - Calcium Channel Blocker combination
|
Titan Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
12 November 2023
|
16 March 2027
|